APA (7th ed.) Citation

Oe, Y., Nomoto, H., Nakamura, A., Kuwabara, S., Takahashi, Y., Yasui, A., . . . Miyoshi, H. Switching from Insulin Degludec plus Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide Improves Glycemic Variability in Patients with Type 2 Diabetes: A Preliminary Prospective Observation Study. Wiley.

Chicago Style (17th ed.) Citation

Oe, Yuki, et al. Switching from Insulin Degludec Plus Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide Improves Glycemic Variability in Patients with Type 2 Diabetes: A Preliminary Prospective Observation Study. Wiley.

MLA (9th ed.) Citation

Oe, Yuki, et al. Switching from Insulin Degludec Plus Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide Improves Glycemic Variability in Patients with Type 2 Diabetes: A Preliminary Prospective Observation Study. Wiley.